1. Home
  2. VTRS vs ELS Comparison

VTRS vs ELS Comparison

Compare VTRS & ELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • ELS
  • Stock Information
  • Founded
  • VTRS 1961
  • ELS 1992
  • Country
  • VTRS United States
  • ELS United States
  • Employees
  • VTRS N/A
  • ELS N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • ELS Real Estate Investment Trusts
  • Sector
  • VTRS Health Care
  • ELS Real Estate
  • Exchange
  • VTRS Nasdaq
  • ELS Nasdaq
  • Market Cap
  • VTRS 12.2B
  • ELS 12.0B
  • IPO Year
  • VTRS N/A
  • ELS 1993
  • Fundamental
  • Price
  • VTRS $10.10
  • ELS $61.90
  • Analyst Decision
  • VTRS Hold
  • ELS Buy
  • Analyst Count
  • VTRS 6
  • ELS 11
  • Target Price
  • VTRS $11.17
  • ELS $70.86
  • AVG Volume (30 Days)
  • VTRS 8.7M
  • ELS 2.3M
  • Earning Date
  • VTRS 11-06-2025
  • ELS 10-22-2025
  • Dividend Yield
  • VTRS 4.72%
  • ELS 3.32%
  • EPS Growth
  • VTRS N/A
  • ELS 2.36
  • EPS
  • VTRS N/A
  • ELS 1.99
  • Revenue
  • VTRS $14,124,400,000.00
  • ELS $1,535,911,000.00
  • Revenue This Year
  • VTRS N/A
  • ELS $1.15
  • Revenue Next Year
  • VTRS $1.61
  • ELS $4.52
  • P/E Ratio
  • VTRS N/A
  • ELS $31.17
  • Revenue Growth
  • VTRS N/A
  • ELS 0.93
  • 52 Week Low
  • VTRS $6.85
  • ELS $58.15
  • 52 Week High
  • VTRS $13.55
  • ELS $73.67
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 46.06
  • ELS 54.14
  • Support Level
  • VTRS $9.92
  • ELS $60.36
  • Resistance Level
  • VTRS $10.95
  • ELS $61.24
  • Average True Range (ATR)
  • VTRS 0.28
  • ELS 1.17
  • MACD
  • VTRS -0.03
  • ELS 0.01
  • Stochastic Oscillator
  • VTRS 17.96
  • ELS 67.26

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About ELS Equity Lifestyle Properties Inc.

Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.

Share on Social Networks: